mTORC2 takes the longevity stAGE

被引：3
|
作者：
Lamming, Dudley W. [1 ,2 ]
机构：
[1] Univ Wisconsin, Dept Med, Madison, WI 53718 USA
[2] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA
来源：
ONCOTARGET | 2014年 / 5卷 / 17期
关键词：
INDUCED INSULIN-RESISTANCE; LIFE-SPAN; RAPAMYCIN; MICE;
D O I：
10.18632/oncotarget.2457
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7214 / 7215
页数：2
相关论文
共 50 条
  • [21] mTORC2 controls potassium secretion
    Andrea Aguilar
    Nature Reviews Nephrology, 2016, 12 (6) : 315 - 315
  • [22] Activation of mTORC2 by Association with the Ribosome
    Zinzalla, Vittoria
    Stracka, Daniele
    Oppliger, Wolfgang
    Hall, Michael N.
    CELL, 2011, 144 (05) : 757 - 768
  • [23] XPLN is a novel regulator of mTORC2
    Khanna, Nidhi
    Fang, Yimin
    Yoon, MeeSup
    Chen, Jie
    FASEB JOURNAL, 2013, 27
  • [24] mTORC1 and mTORC2 in cancer and the tumor microenvironment
    L C Kim
    R S Cook
    J Chen
    Oncogene, 2017, 36 : 2191 - 2201
  • [25] REGULATION AND METABOLIC FUNCTIONS OF mTORC1 AND mTORC2
    Szwed, Angelia
    Kim, Eugene
    Jacinto, Estela
    PHYSIOLOGICAL REVIEWS, 2021, 101 (03) : 1371 - 1426
  • [26] mTORC1 and mTORC2 in cancer and the tumor microenvironment
    Kim, L. C.
    Cook, R. S.
    Chen, J.
    ONCOGENE, 2017, 36 (16) : 2191 - 2201
  • [27] mTORC2 contributes to systemic autoimmunity
    Zhou, Xian
    Qi, Haiyu
    Li, Meilu
    Li, Yanfeng
    Zhu, Xingxing
    Amin, Shreyasee
    Alexander, Mariam
    Diadhiou, Catherine
    Davidson, Anne
    Zeng, Hu
    IMMUNOLOGY, 2023, 168 (03) : 554 - 568
  • [28] MTORC2 brings up the rear
    Rachel David
    Nature Reviews Molecular Cell Biology, 2011, 12 : 74 - 75
  • [29] XPLN is an endogenous inhibitor of mTORC2
    Khanna, Nidhi
    Fang, Yimin
    Yoon, Mee-Sup
    Chen, Jie
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (40) : 15979 - 15984
  • [30] Therapeutic Targeting of mTORC2 in mTORopathies
    Dentel, Brianne
    Escamilla, Christine Ochoa
    Tsai, Peter T.
    NEURON, 2019, 104 (06) : 1032 - 1033
12345